Medigene AG: Medigene AG reports nine months' results 2017
Medigene AG (FSE: MDG1, Frankfurt, Prime Standard, TecDAX), a clinical stage immuno-oncology company focusing on the dev…
Medigene AG (FSE: MDG1, Frankfurt, Prime Standard, TecDAX), a clinical stage immuno-oncology company focusing on the dev…
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immune-oncology company focusing on the development of T…
Early results from an ongoing Phase I/II IIT and a Compassionate Use Programme presented on two posters by academic part…
Medigene AG (MDG1, Frankfurt, Prime Standard) announces that early clinical data of its dendritic cell (DC) vaccines wer…
Trianta Immunotherapies GmbH, a recently founded spin-off from the Helmholtz Zentrum München, has closed a license agree…
The vitamin D supply is one of the key factors for the outbreak and the course of influenza epidemics. Norwegian scienti…
Professor Johan Moan, one of the world's most famous UV and vitamin D researchers, is receiving the renowned research pr…
In order to ensure that the human body receives a balanced level of vitamin D, sun beds should particularly be used in t…